Fiona Maclaughlin, PhD
Fiona Maclaughlin joined Inkef Capital as a Director in 2017 and brings >20 years of experience in the Life Sciences industry, primarily in founding and financing early stage life science companies. Immediately prior to Inkef, Fiona was an Associate at Advent Life Sciences as well as a co-founder of Arrakis Therapeutics. Previously, a Business Development Manager in the Technology Transfer Division of the Wellcome Trust, she evaluated early stage product development opportunities and investments, and established and ran the £45M “R&D for Affordable Healthcare” fund supporting technology development opportunities in India. She also advised life science companies of opportunities in sourcing non-dilutive capital, whilst an Advisor to Tiber Creek Partners, a US-based boutique consultancy. Fiona has >10 years operational experience undertaking exec roles at RepRegen™ Ltd, Gendel Ltd, Phaeton Ltd and Valentis Inc (formerly GeneMEDICINE Inc). She is a Pharmacist by training with a PhD from Nottingham University.